Bristol-Myers Squibb Company (BMY) vs Invesco QQQ Trust, Series 1 (QQQ)
Over the past 10 years, BMY lagged QQQ — 1.08% vs 21.67% annualized total return (price plus dividends).
A side-by-side comparison of Bristol-Myers Squibb Company and Invesco QQQ Trust, Series 1 across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BMY vs QQQ
growth of $100 · last 27yDid BMY beat QQQ?
Over the past 10 years, BMY lagged QQQ — 1.08% vs 21.67% annualized total return (price plus dividends).
Total return (annualized)
| Metric | BMY | QQQ |
|---|---|---|
| Total return (1Y) | 18.37% | 35.85%● |
| Total return CAGR (3Y) | 0.46% | 26.74%● |
| Total return CAGR (5Y) | 0.74% | 16.84%● |
| Total return CAGR (10Y) | 1.08% | 21.67%● |
QQQ is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has BMY beaten QQQ?
- Over the past 10 years, BMY lagged QQQ — 1.08% vs 21.67% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.